Dana-Farber Cancer Institute
NEWS
The decision, which is likely to be appealed, will allow Dana-Farber to license the technology.
Cancer Research UK, a cancer research and awareness charity in the United Kingdom and Isle of Man, recently announced its latest Grand Challenge winners. This cancer research grant awards a series of £20 million wards to international, multidisciplinary teams that focus on unique and new approaches to cancer.
The American Society of Hematology is holding its 60th Annual Meeting & Exposition starting December 1 and running through December 4 in San Diego. Most of the players, big and small, in cancer drug therapies will be there, presenting updates and breaking stories about their hematology pipelines.
Joseph Eid, head of medical at BMS, said Empliciti in combination with pomalidomide and dexamethasone has provided proof that the medication can extend the time a patient can live without the worsening of his or her disease.
Who mixed things up in the biotech world this past week? Pfizer announces its leadership team, Rheos gets a new COO, and board of directors updates from multiple biopharma companies.
Here’s a look at who’s making moves in the biotech and pharma world this week.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Foghorn Therapeutics has officially launched with a $50 million investment and the ambitious goal of altering the way our genes work.
JOBS
IN THE PRESS